Comparison of two commonly practiced atropinization regimens in acute organophosphorus and carbamate poisoning, doubling doses vs. ad hoc: a prospective observational study.
There is a wide variation and lack of evidence in current recommendations for atropine dosing schedules leading to subsequent variation in clinical practice. Therefore, we sought to examine the safety and effectiveness of a titrated vs. ad hoc atropine treatment regimen in a cohort of patients with acute cholinesterase inhibitor pesticide poisoning. A prospective cohort study was conducted in three district secondary referral hospitals in Sri Lanka using a structured data collection form that collected details of clinical symptoms and outcomes of cholinesterase inhibitor pesticide poisoning, atropine doses, and signs of atropinization. We compared two hospitals that used a titrated dosing protocol based on a structured monitoring sheet for atropine infusion with another hospital using an ad hoc regime. During the study, 272 symptomatic patients with anticholinesterase poisoning requiring atropine were admitted to the three hospitals. Outcomes of death and ventilation were analyzed for all patients, 226 patients were prospectively assessed for atropine toxicity. At baseline, patients in the titrated dose cohort had clinical signs consistent with greater toxicity. This in part may be due to ingestion of more toxic organophosphates. They received less pralidoxime and atropine, and were less likely to develop features of atropine toxicity, such as delirium (1% vs. 17%), hallucinations (1% vs. 35%), or either (1% vs. 35%) and need for patient restraint (3% vs. 48%) compared with the ad hoc dose regime. After adjusting for the pesticides ingested, there was no difference in mortality and ventilatory rates between protocols. Ad hoc high dose atropine regimens are associated with more frequent atropine toxicity without any obvious improvement in patient outcome compared with doses titrated to clinical effect. Atropine doses should be titrated against response and toxicity. Further education and the use of a structured monitoring sheet may assist in more appropriate atropine use in anticholinesterase pesticide poisoning.
Perera
P M S
PM
South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. mark@sactrc.org
Shahmy
S
S
Gawarammana
I
I
Dawson
A H
AH
D000328:Adult; D001285:Atropine / Q000627:therapeutic use*; D002219:Carbamates / Q000506:poisoning*; D005260:Female; D006785:Hospitals, University; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D062025:Organophosphate Poisoning; D010575:Pesticides / Q000506:poisoning*; D011041:Poisoning / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D011446:Prospective Studies; D013188:Sri Lanka; D015996:Survival Rate
D002219:Carbamates; D018727:Muscarinic Antagonists; D010575:Pesticides; D001285:Atropine
Ann Intern Med. 1990 Dec 15;113(12):941-8
2240918
Adv Clin Chem. 2004;38:151-216
15521192
Crit Care. 2004 Dec;8(6):R391-7
15566582
Intensive Care Med. 2001 Dec;27(12):1892-900
11797025
Semin Respir Crit Care Med. 2001;22(2):115-26
16088667
Am J Psychiatry. 1999 May;156(5 Suppl):1-20
10327941
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD005085
15654704
Acad Emerg Med. 2003 Apr;10(4):295-8
12670839
Lancet. 2005 Oct 22-28;366(9495):1452-9
16243090
QJM. 2000 Nov;93(11):715-31
11077028
J Toxicol Clin Toxicol. 2004;42(6):865-75
15533026
BMJ. 2001 Jan 20;322(7279):144-9
11159573